| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | 31-Oct-06 | | Total Revenue | 959 | 222,587 | 215,983 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 959 | 222,587 | 215,983 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,502 | 4,373 | 3,574 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
| 3 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,543) | 218,215 | 212,406 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (348,030) | (5) | (0) | | Earnings Before Interest And Taxes | (352,573) | 218,209 | 212,406 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (352,573) | 218,209 | 212,406 | | Income Tax Expense |
-
|
-
| 225 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (352,573) | 218,209 | 212,181 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (352,573) | 218,209 | 212,181 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($352,573) | $218,209 | $212,181 |
|
0.21% Nasdaq 
Income Statement
